NASDAQ
VBLT

Vascular Biogenics Ltd

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Vascular Biogenics Ltd Stock Price

Vitals

Today's Low:
$0.1270
Today's High:
$0.1382
Open Price:
$0.1350
52W Low:
$0.125
52W High:
$2.54
Prev. Close:
$0.1350
Volume:
558801

Company Statistics

Market Cap.:
$0.009 billion
Book Value:
0.496
Revenue TTM:
$0.001 billion
Operating Margin TTM:
-6259%
Gross Profit TTM:
$0.000 billion
Gross Profit TTM:
$0.000 billion
Profit Margin:
0%
Return on Assets TTM:
-39.7%
Return on Equity TTM:
-80%

Company Profile

Vascular Biogenics Ltd had its IPO on 2014-10-01 under the ticker symbol VBLT.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Vascular Biogenics Ltd has a staff strength of 0 employees.

Stock update

Shares of Vascular Biogenics Ltd opened at $0.14 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.13 - $0.14, and closed at $0.13.

This is a -3.78% slip from the previous day's closing price.

A total volume of 558,801 shares were traded at the close of the day’s session.

In the last one week, shares of Vascular Biogenics Ltd have increased by 0%.

Vascular Biogenics Ltd's Key Ratios

Vascular Biogenics Ltd has a market cap of $0.009 billion, indicating a price to book ratio of 0.272 and a price to sales ratio of 16.37.

In the last 12-months Vascular Biogenics Ltd’s revenue was $0.001 billion with a gross profit of $0.000 billion and an EBITDA of $-0.034 billion. The EBITDA ratio measures Vascular Biogenics Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Vascular Biogenics Ltd’s operating margin was -6259% while its return on assets stood at -39.7% with a return of equity of -80%.

In Q2, Vascular Biogenics Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 66%.

Vascular Biogenics Ltd’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
0

Its diluted EPS in the last 12-months stands at $-0.469 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vascular Biogenics Ltd’s profitability.

Vascular Biogenics Ltd stock is trading at a EV to sales ratio of 133.64 and a EV to EBITDA ratio of 0.673. Its price to sales ratio in the trailing 12-months stood at 16.37.

Vascular Biogenics Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Vascular Biogenics Ltd ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Vascular Biogenics Ltd ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Vascular Biogenics Ltd’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Vascular Biogenics Ltd's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Vascular Biogenics Ltd paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.13
52-Week High
$2.54
52-Week Low
$0.125
Analyst Target Price
$5

Vascular Biogenics Ltd stock is currently trading at $0.13 per share. It touched a 52-week high of $2.54 and a 52-week low of $2.54. Analysts tracking the stock have a 12-month average target price of $5.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Vascular Biogenics Ltd

The stock symbol (also called stock or share ticker) of Vascular Biogenics Ltd is VBLT

The IPO of Vascular Biogenics Ltd took place on 2014-10-01

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$0.89
0
+0.45%
$0.53
-0
-0.36%
Nextcure Inc (NXTC)
$2.47
-0.03
-1.2%
$6
-0.08
-1.32%
$12.62
-0.57
-4.32%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Vascular Biogenics Ltd., a clinical biopharmaceutical company, focuses on the discovery, development and commercialization of cancer treatments and immune / inflammatory indications. The company is headquartered in Modi’in, Israel.

Address

HASATAT 8 ST., MODI'IN,, IL